WASHINGTON, March 7, 2016 /PRNewswire-USNewswire/ -- Today, the National Osteoporosis Foundation (NOF), in a joint effort with the Pharmaceutical Research and Manufacturers of America (PhRMA), released a report on new, innovative therapies being developed for the treatment of osteoporosis. The report, Medicines in Development for Osteoporosis, examines the nationwide effects of the disease and explores how new medications can improve and save lives. Nearly 54 million of the 99 million Americans over age 50 in the...
↧
